Skip to main content
Premium Trial:

Request an Annual Quote

Advanced Cell Diagnostics Establishing European Subsidiary

NEW YORK (GenomeWeb) – Advanced Cell Diagnostics today announced the formation of a European subsidiary, to be operational next month.

The company, which is based in Hayward, Calif., said that the subsidiary has a warehouse and distribution center located close to Milan, Italy and sales, marketing, and technical support staff in Germany and the UK. Today's announcement comes shortly after ACD said that its probe library has grown to more than 4,000 probes.

ACD's flagship RNAscope technology is based on in situ RNA detection. The assays have been available for research use only, but the company plans to launch assays for the clinical diagnostics space before the end of the year with an initial focus on human papillomavirus and head-and-neck cancer.

"Establishing a local subsidiary is a natural next step for us to extend our market presence and provide a faster and enhanced level of service to our customers here," ACD Chief Operating Officer Steve Chen said in a statement.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.